Director Market Access Strategy, Access Optimization Lead

Reporting to the Senior Director, Market Access Strategy, Anti-Infective and Respiratory Portfolio Lead, the Director, Market Access Strategy - Access Optimization Lead serves as the enterprise market access leader for assigned brand(s) and indications. This role is responsible for shaping and leading the integrated market access strategy across payer, provider, patient access, pricing and contracting, trade and distribution, and health system channels to maximize brand performance and patient access. This leader acts as the primary market access partner to the brand, serving as a core member of the Integrated Brand Commercialization Team (IBCT) and helping define the strategic choices required to win in a complex and evolving environment. The role is accountable for translating market dynamics, customer insights, competitive intelligence, reimbursement realities, and financial tradeoffs into a clear near-, mid-, and long-term access strategy for the brand. The Director partners across pricing and contracting, account teams, patient experience, trade and distribution, access marketing, access analytics, HEOR / value evidence, finance, policy, medical, and brand teams to align on the integrated strategic plan and ensure execution against the most critical access priorities. Success in this role requires strong strategic leadership, deep market access expertise, and the ability to influence senior stakeholders across a matrixed organization. This position is ideal for a strategic leader who can operate as a peer to brand leadership while bringing a distinct market access lens to brand strategy, launch planning, lifecycle management, and performance optimization. Key Responsibilities 1. Serve as the market access strategy lead for assigned brand(s), accountable for the integrated access strategy across payer, provider, patient support, pricing/contracting, trade/distribution, and organized customer segments. 2. Act as the primary Market Access representative on the IBCT, shaping brand strategy and ensuring access considerations are embedded in core commercial decisions, launch plans, lifecycle planning, and performance discussions. 3. Develop and own the market access strategy, including strategic choices required to optimize access, brand growth, financial performance, and customer pull-through. 4. Lead the development of the brand's access perspective within the integrated brand plan, annual operating plan, and long-range strategic planning. 5. Translate customer, competitor, policy, reimbursement, and market signals into actionable recommendations that evolve the value proposition, evidence needs, strategic priorities, and tactical plan. 6. Partner with pricing and contracting, analytics, HEOR, patient experience, account teams, and trade/channel teams to evaluate choiceful tradeoffs across investments, GTN implications, customer strategies, and launch/lifecycle priorities. 7. Lead cross-functional alignment around access strategy and ensure the broader market access matrix is coordinated against the most important business priorities. 8. Provide clear and timely access guidance to brand and senior leadership on competitive events, reimbursement changes, payer and provider dynamics, organized customer trends, and emerging risks/opportunities. 9. Inform the development of customer-facing resources, evidence communication, segment strategies, and field guidance to ensure the market access strategy is translated into meaningful action. 10. Support launch readiness and lifecycle optimization for new brands, new indications, and portfolio priorities. 11. Build strong relationships across the organization and serve as a trusted strategic advisor on market access issues. Basic Qualifications 1. Bachelor's degree 2. 5+ years of relevant experience in pharmaceutical / biotech market access, access strategy, payer marketing, reimbursement, pricing/contractin , brand strategy, or related commercial roles 3. Experience developing and leading market access strategies 4. Experience working across key access stakeholders, including payers, providers, health systems, organized customers, and channel partners 5. Demonstrated ability to lead cross-functional strategy in a matrixed organization 6. Strong strategic thinking, communication, and influencing skills, including the ability to influence without authority Preferred Qualifications 1. Advanced degree (e.g., MBA, MPH, MS, PharmD) 2. Experience supporting launches, relaunches, and/or new indication launches 3. Experience with Commercial, Medicare, Medicaid, hospital / IDN / health system, and organized customer strategy 4. Experience with 340B, site-of-care dynamics, and provider channel strategy 5. Demonstrated ability to synthesize quantitative analysis and qualitative insight into strategic recommendations 6. Experience making tradeoff decisions across competing initiatives, finite budgets, and GTN / access investment considerations 7. Strong executive communication and presentation skills 8. Experience managing agencies, third-party vendors, and strategic projects Work ArrangementThis role is hybrid. You will be expected to work both on-site and remotely in line with GSK's Performance with Choice approach. Specific on-site expectations will be discussed during the interview process.What we offerYou will join a team committed to collaboration, learning and meaningful impact. You will get exposure to senior leaders and cross-functional partners. You will have the opportunity to shape access strategy for important therapies and to grow your leadership and strategic skills.Apply nowIf this role speaks to you, we encourage you to apply. Share your experience and tell us how you would help more patients access care. We look forward to learning about you. #LI-GSK #GSKCommercial Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees. Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases - to impact health at scale. People and patients around the world count on the medicines and vaccines we make, so we're committed to creating an environment where our people can thrive and focus on what matters most. Our culture of bein